Corticosteroids/β2-agonists in Hair in Asthmatic Patients (CorticHair) (CorticHair)
Therapeutic Drug Monitoring of Corticosteroids/β2-agonists in Hair in Asthmatic Patients: an Open-label Feasibility Study
Sponsor: Hopital Foch
Listed as NCT03691961, this NA trial focuses on Asthma and remains ongoing. Sponsored by Hopital Foch, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Sep 2022 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Feb 2022 — Sep 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Feb 2022 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2019 — Mar 2020 [monthly]
Recruiting NA
-
Nov 2018 — Nov 2019 [monthly]
Recruiting NA
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hopital Foch
For direct contact, visit the study record on ClinicalTrials.gov .